Over the past 12 months, 0 insiders at Baudax Bio, Inc. filed 0 open-market SEC Form 4 transactions on BXRX: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 22 | Geraldine HenwoodPresident and CEO | BUY | 1.2K | $2.55 | $3K |
| Sep 22, 21 | Geraldine HenwoodPresident and CEO | BUY | 8.2K | $0.59 | $5K |
| Aug 31, 21 | Winston J ChurchillDirector | BUY | 100.0K | $0.63 | $63K |
| Aug 20, 21 | Richard S CastenChief Financial Officer | BUY | 50.0K | $0.51 | $26K |
Over the past 12 months, insiders at Baudax Bio, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on BXRX, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market BXRX insider purchase in our data was $63K by Winston J Churchill, Director, filed on Aug 31, 21.
0 different insiders at Baudax Bio, Inc. filed open-market SEC Form 4 transactions on BXRX over the last 12 months.
InsiderTape plots every BXRX insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Baudax Bio, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →